Related references
Note: Only part of the references are listed.Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis
Chongshu Jian et al.
CELL METABOLISM (2020)
A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer
Takuma Tsuchida et al.
JOURNAL OF HEPATOLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Mangiferin Improves Hepatic Lipid Metabolism Mainly Through Its Metabolite-Norathyriol by Modulating SIRT-1/AMPK/SREBP-1c Signaling
Jian Li et al.
FRONTIERS IN PHARMACOLOGY (2018)
Hepatoprotective effect of bisbenzylisoquinoline alkaloid tiliamosine from Tiliacora racemosa in high-fat diet/diethylnitrosamine-induced non-alcoholic steatohepatitis
S. Sylvester Darvin et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease
Paola Dongiovanni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance
Geoffrey A. Preidis et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Mangiferin protects against adverse skeletal muscle changes and enhances muscle oxidative capacity in obese rats
Luz M. Acevedo et al.
PLOS ONE (2017)
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
Antoine Daina et al.
SCIENTIFIC REPORTS (2017)
Antihyperlipidemic and hepatoprotective effects of Gardenin A in cellular and high fat diet fed rodent models
Erenius Toppo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression
Xavier Loyer et al.
GUT (2016)
Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model
J. T. Stefano et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2015)
Data Warrior: An Open-Source Program For Chemistry Aware Data Visualization And Analysis
Thomas Sander et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Troxerutin improves hepatic lipid homeostasis by restoring NAD+-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice
Zi-Feng Zhang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
Non-alcoholic steatohepatitis: an overview including treatments with herbals as alternative therapeutics
Menaka Chanu Thounaojam et al.
JOURNAL OF APPLIED BIOMEDICINE (2012)
Mangiferin Decreases Plasma Free Fatty Acids through Promoting Its Catabolism in Liver by Activation of AMPK
Yucun Niu et al.
PLOS ONE (2012)
Mangiferin exerts hepatoprotective activity against D-galactosamine induced acute toxicity and oxidative/nitrosative stress via Nrf2-NFκB pathways
Joydeep Das et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Leukotriene B4 Is a Physiologically Relevant Endogenous Peroxisome Proliferator-activated Receptor-α Agonist
Venkata R. Narala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Determination of mangiferin in rat plasma by liquid-liquid extraction with UPLC-MS/MS
Dandan Han et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
FXR Regulates Liver Repair after CCl4-Induced Toxic Injury
Zhipeng Meng et al.
MOLECULAR ENDOCRINOLOGY (2010)
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
Maryam Rakhshandehroo et al.
PPAR RESEARCH (2010)
Pharmacophore modeling and parallel screening for PPAR ligands
Patrick Markt et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)
Share Paper
